Guardant Health Inc. (5GH)

Profile

https://guardanthealth.com

Guardant Health Inc. is a precision oncology company that develops blood- and tissue-based tests, data sets, and analytics to support cancer detection and treatment decisions. Its product portfolio includes liquid biopsy tests for tumor mutation profiling, molecular residual disease monitoring, tissue-based genomic profiling, and colorectal cancer screening. The company’s solutions are used across clinical care and research settings to help identify biomarkers, track recurrence, and provide molecular insights from tumor-derived material. Guardant Health serves healthcare providers, laboratories, researchers, and life sciences partners in the United States and internationally, with a focus on noninvasive diagnostics and cancer monitoring. Headquartered in Palo Alto, California, Guardant Health plays a significant role in the growing market for precision medicine and advanced oncology diagnostics.